| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 03/28/2002 | WO2002000266A3 A method of treating and preventing infectious diseases |
| 03/28/2002 | WO2001085770A3 Sentinel virus ii |
| 03/28/2002 | WO2001083692A3 Recombinant aav vectors with aav5 capsids and aav5 vectors pseudotyped in heterologous capsids |
| 03/28/2002 | WO2001055330A3 Recombinant rhabdoviruses as live-viral vaccines for immunodeficiency viruses |
| 03/28/2002 | WO2001051606A3 Cell line for preparing and producing ovine adenovirus vectors |
| 03/28/2002 | WO2001032702B1 Molecular structure of rhd negative locus |
| 03/28/2002 | WO2000061611A9 Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences |
| 03/28/2002 | US20020037576 Method of producing infectious reovirus |
| 03/28/2002 | US20020037575 Recombinant virus vectors |
| 03/28/2002 | US20020037565 Purifying and quantifying adenovirus by ion-exchange chromatography; for example, identifying different adenovirus serotypes |
| 03/28/2002 | US20020037274 Single agent method for killing tumor and tumor associated endothelial cells using adenoviral mutants |
| 03/28/2002 | DE10045016A1 New retroviral vector, useful e.g. in gene therapy, comprises a foreign sequence between primer binding site and splice donor, has better efficiency of gene expression |
| 03/28/2002 | DE10042598A1 Rekombinantes MVA mit der Fähigkeit zur Expression des HER-2/Neu-GENS The recombinant MVA with the ability to express the HER-2 / neu gene |
| 03/28/2002 | CA2423091A1 Viral vectors having tissue tropism for t-lymphocytes, b- and mast cells |
| 03/28/2002 | CA2422564A1 Influenza a virus haemagglutinin subtype h16 proteins and their encoding nucleic acid |
| 03/27/2002 | EP1191105A1 Gene delivery vectors provided with a tissue tropism for T-lymphocytes |
| 03/27/2002 | EP1190249A2 Compounds and methods to enhance raav transduction |
| 03/27/2002 | EP1190056A1 Human cytokine receptor |
| 03/27/2002 | CN1342206A Adenoviruses deleted in IVa2, 100K and/or preterminal protein sequences |
| 03/26/2002 | US6361778 Carboxyl terminal of papillomavirus L1 region is not required for formation of virus-like particles |
| 03/21/2002 | WO2002022807A2 Dermatophagoides nucleic acid molecules, proteins and uses thereof |
| 03/21/2002 | WO2002022663A2 Stress resistant retroviruses |
| 03/21/2002 | WO2002022080A2 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications |
| 03/21/2002 | WO2001068861A3 THREE-DIMENSIONAL MODEL OF A Fc REGION OF AN IgE ANTIBODY AND USES THEREOF |
| 03/21/2002 | WO2001068859A3 Il-17 receptor like molecules and uses thereof |
| 03/21/2002 | US20020034735 Applying mixed solution comprising adenovirus and undesired type of biomolecule to anion exchange chromatography resin containing binding moiety such as dimethylaminopropyl such that adenovirus binds to resin, eluting |
| 03/21/2002 | US20020034733 Novel methods for displaying (poly) pepti des/proteins on bacteriophage particles via disulfide bonds |
| 03/21/2002 | US20020034724 Methods to selectively inactivate microorganisms in biological compositions |
| 03/21/2002 | US20020034521 Botulinum neurotoxin vaccine |
| 03/21/2002 | US20020034519 Modified bovine adenovirus having altered tropism |
| 03/21/2002 | US20020034502 Retroviral vectors |
| 03/21/2002 | US20020034498 Polymer-modified viruses |
| 03/21/2002 | US20020034393 Vector |
| 03/21/2002 | DE10044648A1 Verfahren zur Vermehrung oder zur Entfernung von Cirocoviren aus biologischem Material Method of replication or removal of Cirocoviren from biological material |
| 03/21/2002 | CA2422882A1 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications |
| 03/21/2002 | CA2420459A1 Novel dermatophagoides nucleic acid molecules, proteins and uses thereof |
| 03/20/2002 | EP1188835A1 A vector for the expression of two foreign genes |
| 03/20/2002 | EP1188834A1 Recombinant MVA expressing the HER-2/neu gene |
| 03/20/2002 | EP1187927A2 Hcv/bvdv chimeric genomes and uses thereof |
| 03/20/2002 | EP1187923A1 Apoptosis inhibition by adenovirus e3/6.7k |
| 03/20/2002 | EP1187919A2 Recombinant adenoviruses for the sodium/iodide symporter (nis) |
| 03/20/2002 | EP1187841A1 Method for enhanced protein stabilization and production of cell lines useful for production of such stabilized proteins |
| 03/20/2002 | EP1187530A1 Improved storage and maintenance of blood products including red blood cells and platelets |
| 03/19/2002 | US6358744 Stabilized human papillomavirus formulations |
| 03/14/2002 | WO2002020822A2 Biopanning and rapid analysis of selective interactive ligands (brasil) |
| 03/14/2002 | WO2002020810A1 High efficiency retroviral vector which contains genetically engineered cellular non-coding sequence harboring splicing acceptor |
| 03/14/2002 | WO2002020769A1 Human and mouse targeting peptides identified by phage display |
| 03/14/2002 | WO2002020724A2 Adenoviral targeting and manipulation of immune system response using targeting peptides |
| 03/14/2002 | WO2002020723A2 Compositions and methods for targeting peptides in humans in vivo |
| 03/14/2002 | WO2002020722A2 Methods and compositions for in vitro targeting |
| 03/14/2002 | WO2002020721A2 Vectors derived from south african arbovirus no. 86 |
| 03/14/2002 | WO2002020571A2 Attenuated hiv strains and use thereof |
| 03/14/2002 | WO2002020563A2 RECEPTOR IN THE EDb FIBRONECTIN DOMAIN |
| 03/14/2002 | WO2002020051A2 Equine infectious anemia challenge model for testing vaccines, diagnostics and treatments |
| 03/14/2002 | WO2002020049A2 Eiav chimeric vaccine and diagnostic |
| 03/14/2002 | WO2002020041A2 Eia vaccine and diagnostic |
| 03/14/2002 | WO2001077358A3 Herpes viruses for immune modulation |
| 03/14/2002 | WO2001023001A3 Rapid peg-modification |
| 03/14/2002 | WO2000055335A9 Pseudotyped lentiviral vectors and uses thereof |
| 03/14/2002 | US20020031499 Defective recombinant adenoviruses expressing cytokines for antitumor treatment |
| 03/14/2002 | CA2421783A1 Receptor in the edb fibronectin domain |
| 03/14/2002 | CA2421380A1 Biopanning and rapid analysis of selective interactive ligands (brasil) |
| 03/14/2002 | CA2421271A1 Human and mouse targeting peptides identified by phage display |
| 03/14/2002 | CA2421200A1 Adenoviral targeting and manipulation of immune system response using targeting peptides |
| 03/14/2002 | CA2421195A1 Compositions and methods for targeting peptides in humans in vivo |
| 03/14/2002 | CA2421191A1 Methods and compositions for in vitro targeting |
| 03/13/2002 | EP1186890A1 Srsv detection kit |
| 03/13/2002 | EP1186667A1 Paramyxoviridae virus vector defective in envelope gene |
| 03/13/2002 | EP1186656A1 Method for preparing or removal of circoviruses from biological material |
| 03/13/2002 | EP1186655A1 Packaging cell |
| 03/13/2002 | EP1185661A2 Bacteriophage rm 378 of a thermophilic host organism |
| 03/13/2002 | EP1185660A2 Porcine circovirus vaccine in recombinant poxvirus |
| 03/13/2002 | EP1185628A2 Isolation of a human retrovirus |
| 03/13/2002 | EP1185615A2 Recombinant influenza viruses for vaccines and gene therapy |
| 03/13/2002 | EP1185545A1 Cd4-independent hiv envelope proteins as vaccines and therapeutics |
| 03/13/2002 | EP1185297A2 Streptococcus pneumoniae proteins and vaccines |
| 03/13/2002 | CN1339586A New pronucleus enhancer sample sequence and its use |
| 03/13/2002 | CN1339584A Recombined virus for specific proliferation and high efficiency expression of anti-cancer gene in tumor cells and its constitution method |
| 03/12/2002 | US6355789 Cloned dna sequences related to the entire genomic rna of human immunodeficiency virus ii (hiv-2), polypeptides encoded by these dna sequences and use of these dna clones and polypeptides in diagnostic kits |
| 03/12/2002 | US6355484 Methods and compositions for polypeptides engineering |
| 03/12/2002 | US6355247 Nucleic acid immunization using a virus-based infection/transfection system |
| 03/12/2002 | US6355246 Feline calicivirus isolated from cat urine and vaccines thereof |
| 03/12/2002 | US6355240 Genetic engineering |
| 03/12/2002 | CA2357081A1 Retroviral vectors with foreign-sequence insertion between retroviral primer binding site and retroviral splice donor |
| 03/08/2002 | CA2357404A1 Method for growing or for removing circoviruses from biological material |
| 03/07/2002 | WO2002018909A2 Single riser/single capillary blood viscometer using mass detection or column height detection |
| 03/07/2002 | WO2002018609A2 Methods for stable transduction of cells with viral vectors |
| 03/07/2002 | WO2002018595A2 Moraxella polypeptides and corresponding dna fragments and uses thereof |
| 03/07/2002 | WO2002018585A2 Packaging of positive-strand rna virus replicon particles |
| 03/07/2002 | WO2002018550A1 Selective precipitation of viruses |
| 03/07/2002 | WO2002018426A2 Rabbit hemorrhagic disease vaccine and antigens |
| 03/07/2002 | WO2002018369A2 Peptidomimetic protease inhibitors |
| 03/07/2002 | WO2001056599A3 Hyperthermia and immunotherapy for leukemias, lymphomas, and solid tumors |
| 03/07/2002 | WO2001019870A3 Secreted soluble alpha2delta-2, alpha2delta-3, alpha2delta-4 calcium channel subunit polypeptides and screening assays using same |
| 03/07/2002 | US20020028925 Hsv viral vector |
| 03/07/2002 | US20020028498 Genetically engineered nucleotide sequences for use in the treatment of viral disease and tumors |
| 03/07/2002 | US20020028497 Method for producing recombinant adenovirus |
| 03/07/2002 | US20020028496 Genetic engineering; infecting insect cell with baculovirus; culturing |
| 03/07/2002 | US20020028484 Expression vector for use in the treatment and prevention of viral diseases |
| 03/07/2002 | US20020028212 Recombinant viruses coding for a glutamate decarboxylase (gad) activity |